J.H. Whitney Equity Partners VII LLC Has $262.99 Million Stock Holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

J.H. Whitney Equity Partners VII LLC reduced its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,521,351 shares of the company's stock after selling 134,531 shares during the period. Aveanna Healthcare comprises about 100.0% of J.H. Whitney Equity Partners VII LLC's holdings, making the stock its largest holding. J.H. Whitney Equity Partners VII LLC owned approximately 24.87% of Aveanna Healthcare worth $262,986,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. KLP Kapitalforvaltning AS acquired a new position in shares of Aveanna Healthcare during the 4th quarter valued at about $35,000. BNP Paribas Financial Markets bought a new stake in shares of Aveanna Healthcare in the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC grew its stake in shares of Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after acquiring an additional 6,854 shares during the last quarter. Catalyst Funds Management Pty Ltd increased its position in Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after acquiring an additional 9,000 shares during the period. Finally, Sagespring Wealth Partners LLC acquired a new position in Aveanna Healthcare during the 4th quarter valued at $57,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th. Barclays started coverage on shares of Aveanna Healthcare in a research note on Wednesday, July 2nd. They issued an "equal weight" rating and a $5.50 target price for the company. Wall Street Zen cut shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 27th. Finally, UBS Group increased their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $5.20.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH traded down $0.17 during mid-day trading on Friday, hitting $4.06. The company had a trading volume of 387,222 shares, compared to its average volume of 348,991. The business's 50-day simple moving average is $5.13 and its 200-day simple moving average is $4.86. Aveanna Healthcare Holdings Inc. has a 12 month low of $2.61 and a 12 month high of $6.19. The firm has a market cap of $792.07 million, a P/E ratio of 203.00 and a beta of 1.98.

Insider Activity

In other Aveanna Healthcare news, CAO Deborah Stewart sold 15,457 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $5.56, for a total transaction of $85,940.92. Following the completion of the transaction, the chief accounting officer owned 285,396 shares in the company, valued at $1,586,801.76. This trade represents a 5.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Patrick A. Cunningham sold 18,500 shares of the firm's stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $4.93, for a total transaction of $91,205.00. Following the transaction, the insider owned 327,869 shares of the company's stock, valued at approximately $1,616,394.17. This represents a 5.34% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,115,345 shares of company stock valued at $37,838,057. 7.80% of the stock is owned by company insiders.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.